Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium channel subfamily K member 3 (KCNK3), also known as TASK-1 or K2P3.1, is a member of the two-pore domain potassium (K2P) channel family that mediates background or "leak" potassium currents [1, 10]. These channels are constitutively active at resting membrane potentials and are essential for stabilizing the resting potential and adjusting cellular excitability in tissues such as the heart, lungs, and brain [5, 18]. K2P3.1 is uniquely sensitive to extracellular pH and hypoxia, functioning as a critical physiological sensor in the carotid body to regulate breathing [3, 7]. In the pulmonary circulation, K2P3.1 maintains the resting potential of smooth muscle cells, and its dysfunction—often due to KCNK3 gene mutations—is a primary driver of pulmonary arterial hypertension (PAH) [1, 9]. In the heart, K2P3.1 is predominantly expressed in the atria and contributes to action potential repolarization, making it a target for atrial-selective antiarrhythmic therapies [5, 8]. Pharmacological inhibition of the channel by drugs like carvedilol and amiodarone can prolong the action potential, while its activation by agents like treprostinil helps promote vasodilation [2, 6].
K2P3.1 channels are background potassium channels that stabilize the resting membrane potential; inhibition leads to membrane depolarization and increased cellular excitability or prolongation of the action potential duration, whereas activation causes hyperpolarization and reduced excitability [5, 8, 9].
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel subfamily K member 3 (KCNK3) (K2P3.1).